We also investigated whether potential recovery effects of Empagliflozin were associated with the regulation of glycemia and/or affected other factors involved in stroke recovery, i.e. fibroblast growth factor 21 (FGF-21) [34, 35], increased production of ketone bodies [36, 37], stroke-induced neurogenesis [38, 39], neuroinflammation [40] and post-stroke neovascularization [41]. Here, FGF21 is linked to Stroke.